Defensins are a major class of
antimicrobial peptides that facilitate the immune system to resist pathogen
infection. To date, only β-
defensins have been identified in pigs. In our previous studies, porcine β-
defensin 2 (PBD-2) was shown to have both bactericidal activity and modulatory roles on
inflammation. PBD-2 can interact with the cell surface TLR4 and interfere with the NF-κB signaling pathway to suppress the inflammatory response. In this study, the intracellular functions of PBD-2 were investigated. The fluorescently labeled PBD-2 could actively enter mouse macrophage cells. Proteomic analysis indicated that 37
proteins potentially interacted with PBD-2, among which vasohibin-1 (VASH1) was further tested. LPS, an
inflammation inducer, suppressed the expression of VASH1, whereas PBD-2 inhibited this effect. PBD-2 inhibited LPS-induced activation of Akt, expression and release of the inflammatory mediators
vascular endothelial growth factor and NO, and cell damage. A follow-up VASH1 knockdown assay validated the specificity of the above observations. In addition, PBD-2 inhibited LPS-induced NF-κB activation via Akt. The inhibition effects of PBD-2 on LPS triggered suppression of VASH1 and activation of Akt, and NF-κB and inflammatory
cytokines were also confirmed using pig alveolar macrophage 3D4/21 cells. Therefore, the data indicate that PBD-2 interacts with intracellular VASH1, which inhibits the LPS-induced Akt/NF-κB signaling pathway, resulting in suppression of inflammatory responses. Together with our previous findings, we conclude that PBD-2 interacts with both the
cell surface receptor (TLR4) and also with the intracellular receptor (VASH1) to control
inflammation, thereby providing insights into the immunomodulatory roles of
defensins.